Cell Cryopreservation Market size is anticipated to reach USD 20 Billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of cell cryopreservation was over USD 10 Billion. In recent years, the remarkable progress in cryopreservation techniques stands out as a primary driver propelling the growth of the market. Scientific innovations and technological advancements in preserving biological materials at ultra-low temperatures have significantly enhanced the efficacy and reliability of cell storage, fostering broader applications across various domains. Supporting this notion, a notable statistic underscores the impact of improved cryopreservation techniques on cell viability. Recent studies have reported a substantial increase in post-thaw cell survival rates, with some advanced cryoprotectants achieving recovery rates exceeding 90%. This statistic signifies a marked improvement over traditional methods, where lower survival rates were a common challenge.
The introduction of novel cryoprotectants and the refinement of freezing methods have played a pivotal role in improving cell viability during the cryopreservation process. These advancements address longstanding challenges associated with cell damage and loss of functionality, thereby expanding the scope of applications in biomedical research, drug development, and therapeutic interventions. Cryopreservation is a process of preserving cells, tissues, or other biological materials at extremely low temperatures, usually below -130°C, to maintain their viability for extended periods.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
~8% |
|
Base Year Market Size (2023) |
~ USD 10 Billion |
|
Forecast Year Market Size (2036) |
~ USD 20 Billion |
|
Regional Scope |
|
Type (Cell Freezing Media, Equipment, Consumables)
The cell freezing media segment in the cell cryopreservation market is estimated to gain the largest revenue share of 60% by the year 2036. The growth of cell-based therapies and regenerative medicine underscores the importance of effective cell-freezing media. As more therapeutic interventions harness the potential of living cells, the development of freezing media that ensures the preservation of cell viability becomes crucial for successful clinical applications. Clinical trials utilizing cell-based therapies have seen a notable increase in recent years. A report indicates that there were over 1,000 ongoing clinical trials in regenerative medicine and cell therapy as of 2021. This emphasizes the demand for reliable freezing media to support these therapeutic advancements. The development of advanced cell freezing media is driven by the need to enhance cell viability and post-thaw recovery rates. Optimal formulations with cryoprotectants and additives play a crucial role in minimizing cellular damage during the freezing process, ensuring a higher percentage of viable cells after thawing.
End User (Pharmaceutical, Research and Academic Institutes, Fertility Clinics)
The pharmaceutical segment in the cell cryopreservation market is expected to garner a significant share in the year 2036. The pharmaceutical segment of the market is driven by the imperative need for efficient drug discovery and development. Cryopreserved cells play a crucial role in preclinical studies, allowing pharmaceutical companies to test the efficacy and safety of potential drug candidates before advancing to clinical trials. A study highlighted that cryopreserved human hepatocytes showed enhanced stability and functionality, making them valuable for drug metabolism studies. This underscores the importance of cryopreserved cells in accelerating the drug development process. The pharmaceutical industry's increasing adoption of bioprocessing and biomanufacturing techniques contributes to the growth of the cell cryopreservation market. Cryopreserved cells, particularly cell lines used in the production of biologics, ensure a stable and consistent supply for large-scale manufacturing.
Our in-depth analysis of the global cell cryopreservation market includes the following segments:
|
Type |
|
|
End User |
|
|
Applications |
|
APAC Market Forecast
The cell cryopreservation market in the Asia Pacific region is projected to hold the largest revenue share of 38% by the end of 2036. The increasing prevalence of chronic diseases in the Asia Pacific region is a key driver for the growth of the market. As chronic diseases such as cardiovascular diseases, diabetes, and cancer continue to escalate, there is a growing need for advanced cell-based therapies. According to a report by the World Health Organization (WHO), non-communicable diseases accounted for 71% of all deaths in the Asia Pacific region. This statistic emphasizes the urgent demand for innovative medical solutions, including cell cryopreservation, to support the development of cell-based therapies. Asia Pacific has been at the forefront of stem cell research, contributing to the growth of the cell cryopreservation market. Ongoing advancements in understanding stem cell biology and therapeutic applications are driving the need for effective cryopreservation techniques. The Asia Pacific region is witnessing substantial growth in the biotechnology sector, with a focus on cell-based therapies, genomics, and personalized medicine. The expanding biotechnology industry is a significant driver for the cell cryopreservation market as it necessitates advanced cell preservation methods.
North American Market Statistics
The cell cryopreservation market in the North American region is projected to hold the second-largest share during the forecast period. The elevated prevalence of chronic diseases in North America acts as a significant driver for the cell cryopreservation market. Chronic conditions such as cardiovascular diseases, diabetes, and cancer drive the demand for innovative cell-based therapies, emphasizing the importance of effective cryopreservation techniques. This staggering statistic underscores the urgent need for advanced medical solutions, including cell cryopreservation, to address the increasing burden of chronic illnesses. North America, particularly the United States, plays a pioneering role in biotechnology and scientific research. The region's leadership in innovative research initiatives and cutting-edge technologies fuels the demand for cell cryopreservation, which is integral to preserving the viability of cells used in diverse research applications.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?